Treatment and Management of Autosomal Dominant Polycystic Kidney Disease

Por Helal, Imed
Publicado em 2015-11-18

The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease

Por Reed, Berenice, Helal, Imed, McFann, Kim, Wang, Wei, Yan, Xiang-Dong, Schrier, Robert W.
Publicado em 2012

Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease

Por Helal, Imed, McFann, Kim, Reed, Berenice, Yan, Xiang-Dong, Schrier, Robert W., Fick-Brosnahan, Godela M.
Publicado em 2013

Prevalence of Cardiovascular Events in Patients with Autosomal Dominant Polycystic Kidney Disease

Por Helal, Imed, Reed, Berenice, Mettler, Pamela, Fann, Kim Mc, Tkachenko, Oleksandra, Yan, Xiang-Dong, Schrier, Robert W
Publicado no Am J Nephrol (2012)

Effect of Sevelamer on Mineral and Lipid Abnormalities in Hemodialysis Patients

Por Hamida Fethi, Fatma Lilia, Barbouch Samia, Kaaroud Hayet, Helal Imed, Hedri Hafedh, Abdallah Taieb, Maiz Hedi, Kheder Adel
Publicado em 2008-01-01

Glomerular Hyperfiltration and Renal Progression in Children with Autosomal Dominant Polycystic Kidney Disease

Por Helal, Imed, Reed, Berenice, McFann, Kim, Yan, Xiang-Dong, Fick-Brosnahan, Godela M., Cadnapaphornchai, Melissa, Schrier, Robert W.
Publicado em 2011

Nodular glomerulosclerosis in patients’ without history of diabetes mellitus: a case report

Por Helal, Imed, Goucha, Rym, Karoui, Cyrine, Abderrahim, Ezzedine, Hamida, Fethi Ben, Elyounsi, Fethi, Maiz, Hedi Ben, Abdallah, Taieb Ben, Kheder, Adel
Publicado em 2009